Key Details
| Catalog | MAS-0524-YJ65 |
| Applications | ELISA; IF; Inhib; FC; FuncS |
| Host | Human |
| Reactivity | C. neoformans |
| Clonality | Monoclonal |
| Conjugations | Conjugation could be customized |
| Sub CAT. | Applications | Clone | Conjugations | Endotoxin Level | Size | Quantity | |
|---|---|---|---|---|---|---|---|
| MAS-0524-YJ65-A | ELISA, IF, FC, FuncS | G15-IgG |
Successfully!
|
||||
| MAS-0524-YJ65-B | FC | G19-IgG |
Successfully!
|
Overview
Properties
Target
Overview
| Description | Clones G15-IgG, G19-IgG are Mouse monoclonal IgGs recognize C. neoformans GXM. |
| Reactivity | C. neoformans |
| Applications | ELISA; IF; Inhib; FC; FuncS |
| Host | Human |
| Immunogen | Cryptococcus neoformans serotype D strain 24067 GXM-diphtheria toxoid conjugate |
| Isotype | Human IgG1 KAPPA |
| Clonality | Monoclonal |
| Clone | G15-IgG; G19-IgG |
| Dilutions | ELISA: 0.1-1000 ng/mL |
Properties
| Expression Host | HEK293F/CHO |
| Conjugations | Conjugation could be customized |
| Purification | Protein A/G affinity purified is the regular method |
| Purity | SDS-PAGE> 95% |
| Endotoxin Level | Endotoxin level could be customized |
| Form | Liquid (frequently-used) or lyophilized |
| Concentration | About 1mg/ml. There are differences between batches. Special concentration could be customized. |
| Sterility | 0.2 μM filtered |
| Buffer | See the Datasheet |
| Storage | See the Datasheet |
Target
| Target | C. neoformans GXM |
| Alternative Names | C. neoformans GXM; Cryptococcus neoformans capsular polysaccharides glucuronoxylomanan; GXM; glucuronoxylomanan |
| Introduction | Glucuronoxylomannan (GXM), the principal constituent of the Cryptococcus neoformans capsule, modulates the inflammatory response of human monocytes in vitro. |
| Organism | Fungus |
| Related Disease | Cryptococcosis, cryptococcal meningitis |
| Infections Route | Oral cavity, skin, alimentary canal |
Online Inquiry